Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (l-lactide) for immunization

International Journal of Pharmaceutics

Volumn 420, Issue 1, 2011, Pages 101-110

  Saini, Vinay ^a   Verma, Shiv K ^b   Sahoo, Malaya K ^b   Kohli, Dharm V ^a   Murthy, P Kalpana ^b  

^a DR H S GOUR UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Brugia malayi; CMI; IgG subclasses; Immunoadjuvant; NO; Poly (l lactide)

Indexed keywords

BRUGIA MALAYI EXTRACT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; NITRIC OXIDE; PARASITE ANTIGEN; POLYLACTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ADSORPTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ANIMALS; ANTIBODIES; ANTIGENS, HELMINTH; BRUGIA MALAYI; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FREUND'S ADJUVANT; IMMUNIZATION SCHEDULE; INJECTIONS, SUBCUTANEOUS; INTERFERON-GAMMA; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; PARTICLE SIZE; POLYESTERS; SOLUBILITY; SPLEEN; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES;

EID: 80054706291     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.005     Document Type: Article

References (36)

1. D.R. Absolom, W. Zingg, and A.W. Neumann Protein adsorption to polymer particles: role of surface properties J. Biomed. Mater. Res. 21 1987 161 171 (Pubitemid 17003127)
2. S.A. Babayan, T. Attout, A. Harris, M.D. Taylor, L. Le Goff, P.N. Vuong, L. Renia, J.E. Allen, and O. Bain Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages Int. J. Parasitol. 36 2006 903 914 (Pubitemid 44866806)
3. S. Bhattacharya, U. Singh, P.K. Murthy, and J.C. Katiyar Immunogenicity of purified proteins of Brugia malayi Proceedings of Second Symposium on Vectors and Vector Borne Diseases 1997 149 154
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. V. Chenthamarakshan, K. Cheirmaraj, M.V.R. Reddy, and B.C. Harinath Immunoprophylactic studies with a 43 kDa human circulating filarial antigen and a cross reactive 120 kDa Brugia malayi sodium dodecyl sulphate soluble antigen in filariasis J. Biosci. 22 1997 91 98 (Pubitemid 27344998)
6. J. Chesko, J. Kazzaz, M. Ugozzoli, D.T. O'Hagan, and M. Singh An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles J. Pharm. Sci. 94 2005 2510 2519 (Pubitemid 43081947)
7. A.G. Coombes, E.C. Lavelle, and S.S. Davis Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein Vaccine 17 1999 2410 2422 (Pubitemid 29268364)
8. A.G. Coombes, E.C. Lavelle, P.G. Jenkins, and S.S. Davis Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen Vaccine 14 1996 1429 1438 (Pubitemid 27008258)
9. A.G. Coombes, D. Major, J.M. Wood, D.J. Hockley, P.D. Minor, and S.S. Davis Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines Biomaterials 19 1998 1073 1081 (Pubitemid 28327535)
10. S. Dixit, R.L. Gaur, M.A. Khan, J.K. Saxena, P.S. Murthy, and P.K. Murthy Inflammatory antigens of Brugia malayi and their effect on rodent host Mastomys coucha Parasite Immunol. 26 2004 397 407 (Pubitemid 40364835)
11. 3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm Vaccine 24 2006 5824 5831 (Pubitemid 43947391)
12. W.F. Gregory, A.K. Atmadja, J.E. Allen, and R.M. Maizels The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis Infect. Immun. 68 2000 4174 4179 (Pubitemid 30434572)
13. R.K. Gupta, M. Singh, and D.T. O'Hagan Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines Adv. Drug Deliv. Rev. 32 1998 225 246 (Pubitemid 28267411)
14. I. Jabbal-Gill, W. Lin, P. Jenkins, P. Watts, M. Jimenez, L. Illum, S.S. Davis, J.M. Wood, D. Major, P.D. Minor, X. Li, E.C. Lavelle, and A.G. Coombes Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines Vaccine 18 1999 238 250 (Pubitemid 29443997)
15. I. Jabbal-Gill, W. Lin, O. Kistner, S.S. Davis, and L. Illum Polymeric lamellar substrate particles for intranasal vaccination Adv. Drug Deliv. Rev. 51 2001 97 111 (Pubitemid 32763075)
16. Joseph, S.K., Verma, S.K., Sahoo, M.K., Sharma, A., Srivastava, M., Reddy M.V.R., Murthy, P.K., 2011. IgG subclass responses to proinflammatory fraction of Brugia malayi in human filariasis. Indian J. Med. Res., article ID: ijmr-46-10.
17. K.N. Krithika, P. Dabir, S. Kulkarni, V. Anandharaman, and M.V. Reddy Identification of 38 kDa Brugia malayi microfilarial protease as a vaccine candidate for lymphatic filariasis Indian J. Exp. Biol. 43 2005 759 768 (Pubitemid 41277278)
18. E.C. Lavelle, M.K. Yeh, A.G. Coombes, and S.S. Davis The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol Vaccine 17 1999 512 529 (Pubitemid 29071082)
19. R.M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M.D. Taylor, and J.E. Allen Helminth parasites - masters of regulation Immunol. Rev. 201 2004 89 116 (Pubitemid 39318446)
20. R.M. Maizels, and R.A. Lawrence Immunological tolerance: the key feature in human filariasis? Parasitol. Today 7 1991 271 276 (Pubitemid 121007887)
21. D. Mishra, V. Dubey, A. Asthana, D.K. Saraf, and N.K. Jain Elastic liposomes mediated transcutaneous immunization against hepatitis B Vaccine 24 2006 4847 4855 (Pubitemid 43776800)
22. D. Molyneux Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity Filaria J. 2 2003 13
23. P.K. Murthy, S. Dixit, R.L. Gaur, R. Kumar, M.K. Sahoo, N. Shakya, S.K. Joseph, S. Palne, and S. Gupta Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters Acta Trop. 106 2008 81 89
24. N. Petrovsky, and J.C. Aguilar Vaccine adjuvants: current state and future trends Immunol. Cell Biol. 82 2004 488 496 (Pubitemid 39421058)
25. H. Rafati, E.C. Lavelle, A.G. Coombes, S. Stolnik, J. Holland, and S.S. Davis The immune response to a model antigen associated with PLG microparticles prepared using different surfactants Vaccine 15 1997 1888 1897 (Pubitemid 27504684)
26. S. Ramachandran, M.P. Kumar, R.M. Rami, H.B. Chinnaiah, T. Nutman, P. Kaliraj, and J. McCarthy The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination Microbiol. Immunol. 48 2004 945 955 (Pubitemid 40040702)
27. M.K. Sahoo, B.S. Sisodia, S. Dixit, S.K. Joseph, R.L. Gaur, S.K. Verma, A.K. Verma, A.K. Shasany, A.A. Dowle, and P.K. Murthy Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection Vaccine 27 2009 4263 4271
28. V. Saini, M.K. Sahoo, P.K. Murthy, and D. Kohli Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine Vaccine 27 2009 2372 2378
29. C.S. Schmidt, W.J. Morrow, and N.A. Sheikh Smart adjuvants Expert Rev. Vaccines 6 2007 391 400 (Pubitemid 46911602)
30. S. Shakya, P. Kumar Singh, S. Kushwaha, and S. Misra-Bhattacharya Adult Brugia malayi approximately 34 kDa (BMT-5) antigen offers Th1 mediated significant protection against infective larval challenge in Mastomys coucha Parasitol. Int. 58 2009 346 353
31. T.L. Stevens, A. Bossie, V.M. Sanders, R. Fernandez-Botran, R.L. Coffman, T.R. Mosmann, and E.S. Vitetta Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells Nature 334 1988 255 258
32. N. Stivaktakis, K. Nikou, Z. Panagi, A. Beletsi, L. Leondiadis, and K. Avgoustakis Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres J. Biomed. Mater. Res. A 73 2005 332 338 (Pubitemid 40664299)
33. S. Vedi, A. Dangi, K. Hajela, and S. Misra-Bhattacharya Vaccination with 73 kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models Vaccine 26 2008 5997 6005
34. N. Venkataprasad, A.G. Coombes, M. Singh, M. Rohde, K. Wilkinson, F. Hudecz, S.S. Davis, and H.M. Vordermeier Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers Vaccine 17 1999 1814 1819 (Pubitemid 29172349)
35. S. Wahyuni, R. Van Ree, A. Mangali, T. Supali, M. Yazdanbakhsh, and E. Sartono Comparison of an enzyme linked immunosorbent assay (ELISA) and a radioallergosorbent test (RAST) for detection of IgE antibodies to Brugia malayi Parasite Immunol. 25 2003 609 614 (Pubitemid 38445404)
36. C. Witschi, and E. Doelker Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing J. Control. Release 51 1998 327 341 (Pubitemid 28252884)